Skip to main content
Premium Trial:

Request an Annual Quote

Rick Klausner, Tristan Orpin, and more

Illumina has announced the following changes to its management structure:

  • Rick Klausner, chief opportunity officer, will be leaving the company in the first quarter of 2016.
  • Tristan Orpin has been promoted to executive vice president of clinical genomics.

  • Omead Ostadan has been promoted to executive vice president of operations, products, and strategy.

  • Marc Stapley has been promoted to executive vice president and chief administrative officer. He will continue to act as chief financial officer until a replacement has been appointed.

  • Christian Henry has been promoted to executive vice president and chief commercial officer.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.